Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Danilo Norata

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Scientifica|November 27, 2013
Established and emerging approaches for the management of dyslipidaemiaGiuseppe Danilo Norata
Cardiovascular Research|June 14, 2018
Trained immunity and cardiovascular disease: is it time for translation to humans?Giuseppe Danilo Norata
Giornale Italiano Di Cardiologia (2006)|July 9, 2014
[PCSK9 inhibitors and dyslipidemias: an update on clinical evidence]Giuseppe Danilo Norata
Clinical Biochemistry|May 24, 2014
New therapeutic principles for Familial HypercholesterolemiaGiuseppe Danilo Norata
Molecular Aspects of Medicine|February 8, 2021
Novel acquisitions in cell immunometabolismGiuseppe Danilo Norata, Giuseppe Matarese
Cardiovascular Research|July 27, 2019
Hormonal control of trained immunity: aldosterone at the crossroad between activation of innate immunity and cardiovascular diseasesGiuseppe Matarese, Giuseppe Danilo Norata
Cardiovascular Research|September 29, 2025
The new generation of small interfering RNAs directed against apoprotein(a): focus on the safety and efficacy of zerlasiran and lepodisiranAndrea Baragetti, Giuseppe Danilo Norata
European Heart Journal|November 10, 2023
Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid loweringGiuseppe Danilo Norata, Lale Tokgözoğlu
Pharmacological Research|June 4, 2023
The burden of hypercholesterolemia and ischemic heart disease in an ageing worldAngela Pirillo, Giuseppe Danilo Norata
Cardiovascular Research|September 17, 2020
Dyslipidaemia and regulatory T-cell migration: an immunometabolic connection?Christoph Binder, Giuseppe Danilo Norata
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Scientifica|November 27, 2013
Established and emerging approaches for the management of dyslipidaemiaGiuseppe Danilo Norata
Cardiovascular Research|June 14, 2018
Trained immunity and cardiovascular disease: is it time for translation to humans?Giuseppe Danilo Norata
Giornale Italiano Di Cardiologia (2006)|July 9, 2014
[PCSK9 inhibitors and dyslipidemias: an update on clinical evidence]Giuseppe Danilo Norata
Clinical Biochemistry|May 24, 2014
New therapeutic principles for Familial HypercholesterolemiaGiuseppe Danilo Norata
Molecular Aspects of Medicine|February 8, 2021
Novel acquisitions in cell immunometabolismGiuseppe Danilo Norata, Giuseppe Matarese
Cardiovascular Research|July 27, 2019
Hormonal control of trained immunity: aldosterone at the crossroad between activation of innate immunity and cardiovascular diseasesGiuseppe Matarese, Giuseppe Danilo Norata
Cardiovascular Research|September 29, 2025
The new generation of small interfering RNAs directed against apoprotein(a): focus on the safety and efficacy of zerlasiran and lepodisiranAndrea Baragetti, Giuseppe Danilo Norata
European Heart Journal|November 10, 2023
Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid loweringGiuseppe Danilo Norata, Lale Tokgözoğlu
Pharmacological Research|June 4, 2023
The burden of hypercholesterolemia and ischemic heart disease in an ageing worldAngela Pirillo, Giuseppe Danilo Norata
Cardiovascular Research|September 17, 2020
Dyslipidaemia and regulatory T-cell migration: an immunometabolic connection?Christoph Binder, Giuseppe Danilo Norata
Pageof 18